As more info comes out, its clear that the ideal patient

New Post Public Reply Private Reply Replies (1) Message Board
Patchesohoulihan
723
As more info comes out, its clear that the ideal patient population for brilacidin to show efficacy for Covid is a patient in the US (and therefore benefiting from the synergistic effects with R), one who presents with only moderate symptoms, and one who is not on heparin. There are probably others, but these are the 3 that are jumping out to me.

Out of the 120 in the trial, how many do we think fit this description? In my experience, almost every one of the trial patients would have been placed on subq heparin or lovenox since covid has a known risk of thrombosis. Also (I forget the exact numbers) the vast majority of patient were in Russia, and as far as I know, they did not also receive R. Finally, yesterdays PR states most of the patients presented with severe symptoms. There couldn't have been more than a few patients that were optimized if my above assumptions are correct.

I'm wondering how different the results would be if every patient showed moderate symptoms on admission, also got R, and were placed on different protocols for DVT prophylaxis.

Looking at the new research posted today on bioRxiv, it appears heparin has a significant effect on decreasing brilacidins ability to block viral entry.

I would really like to see another covid trial run, optimized with new info in hand. And who knows, maybe it was optimized. I'm assuming a lot here. Maybe they already new about heparin and trial patients weren't on it. I'm also assuming Russian patients did not get R.

Point is, it doesn't seem like Leo is giving up on Covid, and I agree. The more info we get, it seems this trial was doomed to fail, and could very easily be optimized. I'm very hopeful further trial analysis gets us into a government funded trial
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NextPlat’s 150-Patient Test Has a Long Road Ahead

Updated Category News Views 82

A strip of pills can look mundane, yet it is where this entire NextPlat pitch either earns its keep or falls apart. PharmcoRx has signed a partner pharmacy agreement with MedSure Systems for a 150-patient Medicare medication-adherence pilot in South Florida. That is a small starting line, no two ways around it. Still, the mechanics are more interesting than another vague...

Continue Reading
NetEase Margins Hold Firm as Game Revenue Slips Again

Updated Category News Views 87

A game publisher can look tired at the top line and still be doing plenty right underneath the hood. NetEase’s third-quarter 2026 report is that kind of animal: revenue eased, yet costs behaved, profit rebounded from the prior quarter, and the balance sheet remains absurdly well stocked. For investors in NASDAQ:NTES, this was not a clean victory lap. It was a reminder...

Continue Reading
Cineverse Sets Wolf Creek Return for March 19, 2027

Updated Category News Views 86

A sunburned serial killer is heading back to theaters, and Cineverse has finally put a date on it: March 19, 2027. WOLF CRE3K, formerly called Wolf Creek: Legacy, brings John Jarratt back as Mick Taylor for the third film in the Australian horror franchise. For NASDAQ:CNVS investors, this is not the kind of announcement that lets anyone pencil in revenue with a straight...

Continue Reading
Santa Ana Branch Expansion Tests Local Credit Demand

Updated Category News Views 116

A Bigger Room for Smaller Financial Decisions A branch relocation across the same shopping center may sound mundane, but it says plenty about where California Credit Union sees durable demand. The credit union has opened a larger Santa Ana office at 1601 W. 17th Street, Suite C, replacing its prior spot in the same center. This is not some chest-thumping expansion into an...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 120

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
Getac's Linux Certification Matters at the Rugged Edge

Updated Category News Views 93

Field computers rarely get applause, but they can decide whether a critical operation runs cleanly or turns into a very expensive mess. Getac’s November 19 announcement that its UX10, G140, and V120 rugged devices are certified for Red Hat Enterprise Linux is not the sort of headline that sends investors pounding the table. It is, however, the kind of plumbing work that...

Continue Reading
Nike Locks In Chicago Marathon Partnership Through 2036 Deal

Updated Category News Views 76

Twenty-eight miles of pavement, training plans, and branded shoes are not a quarterly earnings release, but Nike just made a very long-term statement in Chicago. The company and the Bank of America Chicago Marathon have extended their partnership through 2036, preserving a relationship that began in 2008. For a brand rebuilding credibility with runners, that kind of...

Continue Reading
Brightstar Picks Warsop for Its Next CEO Chapter Ahead

Updated Category News Views 112

A Handoff With Plenty Riding on the Rails A lottery supplier changing captains is not usually fireworks, but this one deserves a hard look. Brightstar Lottery has named Thomas Warsop to replace Vince Sadusky as chief executive officer and board member effective January 1, 2027. Sadusky is retiring from both posts on that date. The company is telegraphing an orderly baton...

Continue Reading
M.O.L.I.F.E. Brings Community Inclusion Into Public View

Updated Category News Views 116

A food pantry can reveal more about inclusion than a polished mission statement ever will. M.O.L.I.F.E., Inc. is set to be featured in an educational segment of All Access with Andy Garcia, and the useful part of this story is not the celebrity-host packaging. It is the organization’s insistence that employment, independent living, day programming, residential support,...

Continue Reading
DSFederal Takes On USDA NIFA Grants System Support Work

Updated Category News Views 67

A Quiet Contract With Real Operational Weight Grant paperwork rarely gets anybody’s pulse racing, yet a busted grants system can gum up research money from coast to coast in a hurry. DSFederal has won work supporting the U.S. Department of Agriculture’s National Institute of Food and Agriculture, or NIFA, through its Grants Management and Reporting System, known as...

Continue Reading

Top 5 Most Recently Viewed Articles

SiriusPoint Completes $250 Million ArmadaCare Transaction

Updated Category News Views 206

SiriusPoint's Strategic Sale of ArmadaCare SiriusPoint Ltd. has made waves in the insurance market by announcing the sale of its wholly owned subsidiary, ArmadaCare, to Ambac Financial Group Inc. for an impressive $250 million. This transaction represents a pivotal moment for SiriusPoint as it continues to forge forward in its commitment to growth and strategic...

Continue Reading
Lexia Aspire: A New Standard in Educator Accreditation

Updated Category News Views 167

Lexia Aspire Achieves Prestigious IDA Accreditation Lexia Aspire Professional Learning, an innovative professional learning solution grounded in the science of reading, has been honored with the International Dyslexia Association (IDA) Accreditation Seal. This accolade stems from the IDA's Program Review and Accreditation initiative designed to evaluate and enhance...

Continue Reading
Unlocking Portfolio-Level Trading for High-Net-Worth Individuals

Updated Category News Views 150

Understanding Portfolio-Level Trading High-net-worth traders today are realizing that achieving sustainable trading success is not just about managing a single account. Instead, the emphasis is shifting towards a portfolio-level trading strategy, which distributes exposure across various accounts, strategies, and market conditions. This change highlights a significant...

Continue Reading
GHO Capital Secures Over €2.5bn to Enhance Healthcare Investments

Updated Category News Views 452

GHO Capital Closes Fourth Fund with Significant Investment Global Healthcare Opportunities (GHO) has announced an impressive milestone with the final closing of its fourth fund, GHO Capital IV LP, which successfully raised over €2.5 billion. This substantial amount is set to enhance GHO’s ongoing mission of transforming healthcare accessibility and innovation...

Continue Reading
Exploring the Expansive Growth in the Wet Tissue Market

Updated Category News Views 212

Key Insights into the Wet Tissue and Wipe Market Growth The global wet tissue and wipe market is poised for substantial growth, with an estimated increase of USD 10.78 billion between 2024 and 2029. This expansive growth can be attributed to the rising consumer demand for hygiene products and the convenience they offer in various applications. Recent trends show that the...

Continue Reading